Announcements Trials

Browse Landscape

Phase

Status

Completed 11 Terminated 6 Active not recruiting 3 Unknown 2 Recruiting 2 Withdrawn 1 Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Injections 39 Carboplatin 33 Capecitabine 24 Paclitaxel 23 Cisplatin 23 Docetaxel 22 pembrolizumab 21 Oxaliplatin 21 Gemcitabine 21 Bevacizumab 19 Pemetrexed 18 Fluorouracil 13 Irinotecan 12 Cyclophosphamide 11 osimertinib 9 Nivolumab 9 Dexamethasone 8 Topotecan 7 Leucovorin 7 130-nm albumin-bound paclitaxel 7 venetoclax 6 toripalimab 6 tislelizumab 6 regorafenib 6 lenvatinib 6 fludarabine 6 Doxorubicin 6 Cetuximab 6 daratumumab 5 atezolizumab 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × INDUSTRY × Lomustine × Clear all

NCT07120984 2025-08-13

IMAGLIO

Philogen S.p.A.

Phase 2 Not yet recruiting

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡